¤îµhÃĤ]·|­P©R¡I
ÂÔ·V¬D¿ï ¤Á¤Å¹L¶q

[2016.03.08] µoªí
¿ï¥ÎÃĶK¥D­n¬Ý¦¨¤À¡A¶K¦b¨­¤W¬O§N¬O¼ö¡A¥u¬O­Ó¤H·Pı¡A¹ïÀø®Ä¨S¦³ª½±µÃö«Y¡C
«Ü¦h¤îµhÃĪº¥~»ª¤Î¦¨¤À¦WºÙ¬Ý¦ü¤£¦P¡A¦ý¨ä¹ê¦¨¤À¬O¤@¼Ë¡C
¹³Celecoxib³oÃþÄÝ·s¤@¥Nªº®øª¢¤îµhÃÄ¡A¸û¤Ö¤Þ°_¸z­G¤£¾A¡A¦ý»Ý­nÂå¥Í³B¤è¡C

µh¡A§A§Ú³£¸Õ¹L¡C

­±¹ïµh¯g¡Aµ§ªÌ¨­Ã䪺ªB¤Í¡A³Ì±`¨£¦³¨âºØ¤ÏÀ³¡A¤@¬O§Ô±o´N§Ô¡AºÉ¶q¤£ªg¤W¥b¤f¤îµhÃÄ¡A²`©È·|´Ý¯dÅ餺³y¦¨¶Ë®`¡F¥t¤@¬Oµø¬°¤f³UùØ¥²³Æ¨}ÃÄ¡A¯S§O¬O¤k«Ä¤l¨C¤ë¥Í²zµh¡A§óµø¤§¬°±Ï¬P¡C

¥h¦~¡A¬ü°ê¤@¦WµØ¸Ç¤kÂå¥Í³Q±±Àݶ}¤îµhÃÄ¡A¾É­P¤T¦W¦~»´¨k¤l¦º¤`¡F¿D¬wÄvª§©M®ø¶OªÌ©e­û·|«hµo²{¡ANurofen¤îµhÃĪº¯S®Ä°t¤è»P´¶³q°t¤è¦¨¤À¤@¼Ë¡A¦³»~¾É®ø¶OªÌ¤§¶û¡A³¡¤À­n¤U¬[¡C­±¹ï¥«­±¤W¤£¦P°t¤èªº¤îµh¦¨ÃÄ¡A§{¶¡½T¦s¦b«Ü¦h¬y¨¥ÂÕ¨£¡C¨ì©³­n«ç¼Ë­¹¥Î¡A¤~¦w¥þ¤S¹F¨ì³Ì¨Î®ÄªG©O¡H¤µ¦¸©î¸Ñ·í¤¤ªº¦¨¤À¤Î¨ä¹ï¨­Å骺¼vÅT¡C

¤îµh¤]¦³¤T¯Å¨î

¥«­±ªº¤îµh¦¨ÃĦh¦pÁc¬P¡A¬Ý±o¤H²´ªá¼º¶Ã¡C­»´ä¤¤¤å¤j¾ÇÃľ¯¾Ç°|°Æ±Ð±Â§õµú®¦«ü¡A¤îµhÃÄ¥D­n¦¨¤À¬°¥H¤U¤T¤jÃþ¡G

1.¹Mªº¼³®§¼öµh(Paracetamol)¡AÄݲĤ@½uÃĪ«

³oÃþÃĪ«¤£¥ÎÂå¥Í³B¤è¤]¥i¶R¨ì¡C¥¦¨ã¤îµh¤Î°h¿N¥\®Ä¡A°Æ§@¥Î¤Ö¡A¬Û¹ï¸û¦w¥þ¡A¦ý¨S¦³®øª¢§@¥Î¡C¨ä¨C¤é¤W­­¬°4000mg¡C(¦p¨C²É500mg¡A§Y¨C¤Ñ³Ì¦h¦Y8²É)¡A¨C¦¸¤£¯à¶W¹L1000mg(§Y¬ù¨â²É)¡A§_«h©Î·|·l®`¨x¥\¯à¡AÄY­«ªÌ·|¥O¨x¤¤¬r¡C

2.©T¾J®øª¢ÃÄ(²ºÙNSAIDs)¡AÄݤG½uÃĪ«

¥¦ªº¥Î³~¼sªx¡A³Ì±`¨£¦³¤ô·¨»Ä(Salicylic acid)Ãþªº¤îµhÃÄ¡A¥ç§Y¬O¨È¤h¤ÇÆF(Aspirin)¡B¥¬¬¥ªâ(Ibuprofen)µ¥¡C¡u³oÃþÃÄ·|¨ë¿E­G¾À©ö¶Ë¸z­G¡A©y»P­GÃĦPªA¡CªA¥Î¶W¹L¤T¦Ü¤»­Ó¤ë¡A©Î¼vÅTµÇ¥\¯à¡C¡vºC©Ê¯f¡B¿}§¿¡BµÇ¥\¯à¸û®tªº¯f±w­n¯S§O¤p¤ß¡C²{®É¤w¦³·s¤@¥Nªº®øª¢¤îµhÃÄCOX-II inhibitors¡A¹³Celecoxib¡A·|¸û¤Ö¤Þ°_¸z­G¤£¾A¡C³q±`³o¤G¯ÅÃĪ«¡A»Ý¸gÂå¥Í³B¤è¡C

3.©Î¸û²`µh·¡ªº¯f¤H·|±`¥Î¨ìªº¦pTramadol¡BCodeineµ¥¡C

³o¨Ç§t¶Ü°ØÃþªºÃĪ«¡AÄݺʺÞÃĪ«¡A¤@¯ë¥Î©ó»´¦Ü¤¤«×¯kµh¡A©Î°µ¤p¤â³N¡C¡uTramadol¥D­n§íÀ£¸£³¡¯«¸g¤º¤@ºØ¤¸¯À¡A¨ä°Æ§@¥Î¬OÀY·w¡B¹Ã¦R¤Î«K¯µ¡A¦Ó¯fªÌªA«á·|±`·P¯h­Â¡B¶ÝºÎ¡A·|¼vÅT±wªÌªº¤ÏÀ³¡A¬Gµ´¤£¯à¶}¨®¡C¡v

ÃĶK¤£¯à¶W¹L¤K¤p®É

¤îµhÃij̱`¨£¤fªA¥~¡AÁÙ¦³ÀR¯ßª`®g¡B¥Ö¤Uª`®g¡B¥~¼Å©Î¶ë¨zªùµ¥¡C¦b²³¦h¤è¦¡¤¤¡AÃĶK¤j³¡¤À§t¤ô·¨»Ä(Salicylic acid)¡A¨C¤é¤£¯à¶W¹L4000mg¡C¦ý¦]³¡¤ÀªøªÌ¦³®É·|¤j½d³ò¶K¤W¦h¶ôÃĶK¡A¾É­P§l¦¬¹L¶q¡C¦pªø´Á¨Ï¥Î¡A§ó¥i¯à¼vÅTÅ餺¦å¤pªO«ü¼Æ¡A­°§C¨ä¾®¦å¥\¯à¡A¼W¥[¬y¦å¾÷·|¡C¦pÃĶK¥[¤W·x¥]¡B·x¤ô³U¼ö¼Å¡A¼W§Ö³Q§l¦¬¡A·|¼W¥[°Æ§@¥Î¾÷·|¡C¤@¯ëÃĶK¥|¦Ü¤»¤p®É«K­n§ó´«¡A¤K¤p®É¤w«Üªø¡A¤£©y¶K¹L©]¡C

¤£ª¾¤£Ä±¦Y¹L¶q

§õµú®¦¶i¦æ¥~®i¤u§@®Éµo²{¡A´¿±µÄ²¤E¤d¦h¦ìªøªÌ¤¤¡A¦]¦b¤£¦P®É¶¡¬ÝÂå¥Í¡A¤£ª¾¹DÀò¬£­«½ÆÃĪ«¡A¤S©ÎªÌ¦]³¡¤ÀÃĪ«¥~»ª¤£¦P¡A¦ý¦¨¤À¬Û¦P¡A¯f¤H¤£ª¾´NùؤU­«½Æ¥ÎÃÄ¡C¡uÁÊÃÄ«e­n¬Ý¦¨¤À«Ü­«­n¡A´Nºâ¦P¬O§t¼³®§¼öµh¡A³¡¤ÀÃÄ·|¥[¤J¦pChlorpheniramine¡BDiphenhydramineµ¥§Ü±Ó¡B¦¬»ó¤ôµ¥¦¨¤À¡C¦p§A¨S§i¶DÂå¥Í¡A¤S©Î¦Û¦æ¦AªA¥Î¦¨ÃÄ¡A¦¹®É«K³Ì®e©öªA¥Î¹L¶q¤F¡C¡v

¬D¿ïÃĪ«¬Ý¦¨¤À

­n¬D¿ï¦³®Äªº¤îµhÃÄ¡A³Ì­«­nÁÙ¬O¬Ý¦¨¤À¡C§õµú®¦«ü¦p¶Ë­··P«_¡B¦Ù¦×µmµh¡A¹³­¹¥Î¼³®§¼öµh¬O¦³®Äªº¡A¦Ó¨ä§t¶q·U°ª¡A¤îµh¯à¤O·U±j¡C¦ý³¡¤À¯kµh¬O¥Ñ¨ä¥L¯e¯f¤Þ°_¡A¹³Ãö¸`µh¡A¤îµh¥uªv¼Ð¡A¤£¬Oªv¥»¡A©y§ä¥X¯f¦]¹ý©³®Úªv¡C¦o¤S«ü¡A¦³¨Ç¯S®Ä°t¤è¡A¦]Ãļt±N¤è¾¯³]­p¨ì¯à§Y®É·»¸Ñ¡A©ö³Q¸z­G§l¦¬¡A¬G¯à¦b¸ûµu®É¶¡¤îµh¡C¤£¹L¡A¦pªA¥Î«á«ùÄò¤C¤é¤´¦bµh¡A¦Ó¥Bµh·¡¥[¼@¡A´N©y°¨¤W¥h¬ÝÂå¥Í¡C

­J¶Ã­¹¥Î·|«æ©Ê¨x°IºÜ

§õ«ü¤@¯ë«D³B¤èªº¤îµhÃÄ¡A¦]¨äÃĪ«¬ù¥|¤p®É«K¶i¤J¥b°I´Á(half life)¡A¤£ºâ¤Óªø¡A©ö³Q¨xŦ¤À¸Ñ¤Î±Æ¥X¡A¤£·|¿n»EÅ餺¡C¤£¹L¡A¤@¦¸¹LªA¥Î¹L¶q¤îµhÃÄ¡A¬O¦³¾÷·|­P©R¡C§õµú®¦´¿¨£¹L¤Ü´X·³¤k¯f¤H¡A¥H°s°eªA¼Æ¤Q²É¤îµhÃÄ¡A¾É­P«æ©Ê¨x°IºÜ¡A³Ì«áªð»î¥F³N¡C¦o»¡­n¨Ì¨¬¼ÐÅÒ¤W«ü¤Þ¡A§O¦Û¦æ½Õ¸ûÃĪ«¤À¶q¬O«Ü­«­n¡A¦Ó­n¯d·N¦³§_°Æ§@¥Î¤ÏÀ³¡C

¦b¥~°êÁÊÃĦ³­·ÀI

«Ü¦h´ä¤H¥~¹C¡A³ßÅw¶RÃĩΰ·±d­¹«~¸É¥R¾¯¡C¦ý§õ«ü¦³¤@©w­·ÀI¡C¡u¥~°ê«Ü¦hÃĪ«¼ÐÅÒ¤£¬O¥Î¤¤¡B­^¤å¼Ð¥Ü¡A«ÜÃø¬d¨s©Ò§t¦¨¤À¡A¦Ó´Nºâ¬O­^¤å¼Ð¥Ü¡A¦ý¦]¤£¦P°ê®aµù¥UÃĪ«¦WºÙ¦³§O¡AÄ~¦Ó¥X²{°ÝÃD¡C¦p¼³®§¼öµh¡A­»´ä¡B­^°ê¤Î¼Ú¬wºÙ¬°Paracetamol¡A¦b¬ü¥[«hºÙAcetaminophen¡A¦ý©Ò«ü³£¬O¬Û¦P¦¨¤À¡C¬GÁʶR«e­n¥ý¦V·í¦aÃľ¯®v¬d¸ß¡C¡v

§ó¦h°·±dÂå¨Æ
Âå¨Æ±MÄæ¡G¡m³Ì«á¤@½Ò¡n
¤å ³ÁÞm©M | ¹Ï Don Mak Âå¾Ç°|²¦·~Á{§É¸Õ¡C¦Ò©x¥Ò¡G¡u§A»¡±wªÌªº¤ßŦµÎ±i©ÊÂø­µ¬O¥Ñ¤G¦yä¯U¯¶³y¦¨¡A§AªÖ©w¶Ü... ¸Ô±¡

©ú³øºô¯¸ ¡P ª©Åv©Ò¦³ ¡P ¤£±oÂà¸ü
Copyright © 2016 mingpaocanada.com All rights reserved.
Ming Pao Daily News A wholly owned subsidiary of Ming Pao Enterprise Corporation Ltd.
Toronto Chinese Newspaper

1355 Huntingwood Drive, Scarborough, Ontario, Canada M1S 3J1 | Tel.: (416) 321-0088 | Fax: (416) 321-9663 | Advertising Hotline Tel: (416) 673-8250